Envestnet Portfolio Solutions’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-8,005
Closed -$813K 1348
2025
Q4
$813K Sell
8,005
-4,411
-36% -$354K ﹤0.01% 840
2025
Q3
$679K Sell
12,416
-1,739
-12% -$86.9K ﹤0.01% 904
2025
Q2
$752K Sell
14,155
-58,727
-81% -$2.98M ﹤0.01% 911
2025
Q1
$3.16M Buy
72,882
+55,063
+309% +$2.79M 0.01% 479
2024
Q4
$1M Sell
17,819
-2,106
-11% -$131K ﹤0.01% 925
2024
Q3
$1.36M Buy
19,925
+432
+2% +$24.4K ﹤0.01% 796
2024
Q2
$824K Sell
19,493
-296
-1% -$16.3K ﹤0.01% 929
2024
Q1
$1.37M Sell
19,789
-2,130
-10% -$135K 0.01% 747
2023
Q4
$1.62M Buy
21,919
+1,200
+6% +$78.7K 0.01% 649
2023
Q3
$1.41M Buy
+20,719
New +$1.76M 0.01% 654

Other funds holding EXAS

Envestnet Portfolio Solutions's EXAS Position: Q1 2026 in Review

Envestnet Portfolio Solutions sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 8,005 shares — an estimated $813K sold.

Envestnet Portfolio Solutions first reported a position in EXAS in Q3 2023 and held it in 10 quarters. The position peaked at $3.16M in Q1 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Envestnet Portfolio Solutions reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Envestnet Portfolio Solutions sold 8,005 Exact Sciences shares in Q1 2026, an estimated $813K.
  • Envestnet Portfolio Solutions first reported a position in Exact Sciences in Q3 2023 and held it in 10 quarters.
  • Envestnet Portfolio Solutions's Exact Sciences position peaked at $3.16M in Q1 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Envestnet Portfolio Solutions's 13F filing for Q1 2026, filed 29 Apr 2026.